Inspecs Navigates Weak Demand and Tariff Headwinds Amidst Acquisition Bids
Inspecs Group, the UK-based eyewear designer, manufacturer, and distributor, recently delivered a challenging trading update amidst ongoing acquisition interest. The company continues to grapple with prevailing weak consumer demand and persistent disruptions stemming from US tariffs, factors that have significantly impacted its recent performance.
For the 10 months concluding on 31 October, Inspecs reported that the initial two months of the second half of the year lagged "slightly behind plan." While trading saw an improvement in October, particularly with its US-based eyewear subsidiary Tura achieving stronger-than-expected sales and a 10% increase in order books year-on-year by month-end, overall operational weakness persisted across the group.
Despite the positive turn in October and a continued emphasis on cost-saving initiatives, Inspecs noted that the sustained US tariff disruptions and the ongoing weak macroeconomic climate are anticipated to affect the timing of product shipments, especially from its sister manufacturer, Killine. Consequently, the group has revised its financial outlook, now projecting revenues of approximately £191 million and underlying EBITDA of around £17.7 million for the full year ending 31 December.
These projections stand in contrast to the prior year's performance, where group revenue modestly increased to £203.3 million, though it saw a slight decline at constant exchange rates. At that time, CEO Richard Peck highlighted it as a record sales performance, marked by an increased number of frames sold, despite a slower-than-expected close to the year. The underlying EBITDA for the year-ago period was also notably higher, coming in at £18 million, representing a 16% increase.
The current financial headwinds and revised forecasts for Inspecs Group are undoubtedly being closely monitored by various rivals and potential investors, especially given that formal offers for either the entire business or specific parts of it were submitted as recently as last month. This heightened interest underscores the strategic value of Inspecs within the global eyewear market.
Among the publicly disclosed proposals, Italian eyewear giant Safilo confirmed a non-binding offer for Inspecs' German operations, specifically targeting Eschenbach Group and BoDe. Furthermore, Inspecs has received "two separate, unsolicited proposals" from H2 Equity Partners and a consortium comprising Risk Capital Partners and Ian Livingstone. Both H2 and the Consortium have put forward non-binding possible cash offers, with an alternative option including unlisted securities, aiming to acquire the entire issued and to be issued share capital of Inspecs.
A critical deadline looms for both H2 Equity Partners and the Risk Capital Partners/Ian Livingstone Consortium. They are mandated to announce a "firm intention" to make an offer, or conversely, to declare that they do not intend to proceed, by no later than 5pm UK time today, 20 November. While an extension to this deadline remains a possibility, the immediate timeframe creates a sense of urgency for these potential suitors.
It comes as little surprise that Inspecs, and elements of its robust business, have become appealing acquisition targets. The company operates in a particularly buoyant segment of the optical and fashion industries, supplying to over 80 countries and approximately 75,000 points of sale worldwide. Inspecs designs and markets its own successful eyewear brands and holds valuable licenses for prominent names such as O'Neill, Barbour, Joseph, Radley, Superdry, Temperley, and Viktor & Rolf, among others, solidifying its strong position in the global market.
